Welcome to
RBP World!
Drugs target to CASP7
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| EMRICASAN | Small molecule | cirrhosis of liver | Caspase inhibitor | 2.0 | Unknown status | ClinicalTrials |
| EMRICASAN | Small molecule | liver disease | Caspase inhibitor | 1.0 | Completed | ClinicalTrials |
| EMRICASAN | Small molecule | gastrointestinal disease | Caspase inhibitor | 1.0 | Completed | ClinicalTrials |
| EMRICASAN | Small molecule | Hepatitis, Alcoholic | Caspase inhibitor | 2.0 | Terminated | ClinicalTrials |
| EMRICASAN | Small molecule | cirrhosis of liver | Caspase inhibitor | 2.0 | Completed | ClinicalTrials |
| EMRICASAN | Small molecule | diabetes mellitus | Caspase inhibitor | 1.0 | Completed | ClinicalTrials |
| EMRICASAN | Small molecule | non-alcoholic steatohepatitis | Caspase inhibitor | 2.0 | Completed | ClinicalTrials |
| EMRICASAN | Small molecule | COVID-19 | Caspase inhibitor | 1.0 | Terminated | ClinicalTrials |
| EMRICASAN | Small molecule | chronic hepatitis C virus infection | Caspase inhibitor | 2.0 | Completed | ClinicalTrials |